Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

273
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
273
Introduction to Epidemiology01:26

Introduction to Epidemiology

777
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
777
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

297
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
297

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Keeping up with the regions: a hybrid machine learning framework for estimating regional input-output tables.

Scientific reports·2026
Same author

Innovative approaches to collecting, aggregating, and analyzing adverse drug events in smart hospitals.

The International journal of risk & safety in medicine·2025
Same author

Benchmark dose modeling for epidemiological dose-response assessment using case-control studies.

Risk analysis : an official publication of the Society for Risk Analysis·2024
Same author

Quantitative Integration of Mode of Action Information in Dose-Response Modeling and POD Estimation for Nonmutagenic Carcinogens: A Case Study of TCDD.

Environmental health perspectives·2023
Same author

The Effect of Historical Data-Based Informative Prior on Benchmark Dose Estimation of Toxicogenomics.

Chemical research in toxicology·2023
Same author

Incentives for Research Effort: An Evolutionary Model of Publication Markets with Double-Blind and Open Review.

Computational economics·2023

Related Experiment Video

Updated: Jul 21, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K

Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies.

Francesco De Pretis1,2, Yun Zhou1, Pengcheng Xun3

  • 1Department of Environmental and Occupational Health, School of Public Health, Indiana University Bloomington, Bloomington, Indiana, USA.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|July 27, 2023
PubMed
Summary

Benchmark dose (BMD) methodology is adapted for epidemiological data. The adjusted relative risk (RR)-based approach is more generalizable for regulatory risk assessment than the "effective count" method.

Keywords:
Bayesian analysisarsenic exposurebenchmark dosebladder cancerepidemiological risk assessmentlung cancer

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 21, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

Area of Science:

  • Environmental health
  • Toxicology
  • Epidemiology

Background:

  • Benchmark dose (BMD) methodology is standard for chemical risk assessment using toxicological data.
  • Existing BMD frameworks are not well-suited for diverse epidemiological study designs and data formats.
  • Recent advancements allow BMD analysis for cohort and case-control studies using summary data.

Purpose of the Study:

  • To compare "effective count" and adjusted relative risk (RR)-based BMD modeling for epidemiological data.
  • To identify a generalizable BMD modeling framework for published prospective cohort study data.
  • To support regulatory chemical risk assessment with robust epidemiological data analysis.

Main Methods:

  • Applied two BMD modeling approaches: "effective count" and adjusted RR.
  • Utilized published studies on inorganic arsenic exposure and cancer (bladder, lung).
  • Compared the generalizability and consistency of estimated BMD and BMDL values.

Main Results:

  • Estimated BMD and BMDL values were relatively consistent between the two methods.
  • The adjusted RR-based BMD approach demonstrated greater generalizability.
  • This approach aligns with established BMD analysis practices for toxicological data.

Conclusions:

  • The adjusted RR-based BMD modeling is a more harmonized and generalizable approach for epidemiological data.
  • This framework facilitates consistent application of BMD methodology across toxicological and epidemiological studies.
  • The findings support improved regulatory risk assessment through standardized analysis of published epidemiological research.